Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Announcement & Circular
Stock Information
02186.HK
2.87 0.05  (1.77%)
TradingVolume：535.1
06-27
2024
THE MANUFACTURING FACILITY OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) HAS PASSED PAI BY U.S. FDA WITH NO FDA-483 (78KB)
Publisher：
06-20
2024
JINYOUPING (ROTIGOTINE MICROSPHERES FOR INJECTION) APPROVED FOR MARKETING IN CHINA
Publisher：
06-06
2024
MEIBIRUI (PALIPERIDONE PALMITATE INJECTION) APPROVED FOR MARKETING IN CHINA
Publisher：
06-06
2024
NDA FILED FOR RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH IN JAPAN
Publisher：
06-04
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
Publisher：
05-28
2024
Notification Letter and Request Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Publisher：
05-28
2024
Altered Memorandum of Association and Bye-laws
Publisher：
05-28
2024
Notification Letter and Request Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
Publisher：
05-28
2024
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2024
Publisher：
05-06
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
Publisher：
First
1
2
3
4
5
Last
Investors
Announcement & Circular
Corporate Governance
Financial Results
IR Activities
Contact Us
Stock Information
02186.HK
TradingVolume：535.1
2.87
0.05  (1.77%)
Announcement & Circular
06-27
2024
THE MANUFACTURING FACILITY OF PALIPERIDONE PALMITATE EXTENDED-RELEASE INJECTABLE SUSPENSION (LY03010) HAS PASSED PAI BY U.S. FDA WITH NO FDA-483 (78KB)
06-20
2024
JINYOUPING (ROTIGOTINE MICROSPHERES FOR INJECTION) APPROVED FOR MARKETING IN CHINA
06-06
2024
MEIBIRUI (PALIPERIDONE PALMITATE INJECTION) APPROVED FOR MARKETING IN CHINA
06-06
2024
NDA FILED FOR RIVASTIGMINE TWICE WEEKLY TRANSDERMAL PATCH IN JAPAN
06-04
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 May 2024
05-28
2024
Notification Letter and Request Form to Non-registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
05-28
2024
Altered Memorandum of Association and Bye-laws
05-28
2024
Notification Letter and Request Form to Registered Shareholders - Arrangement of Electronic Dissemination of Corporate Communications
05-28
2024
POLL RESULTS OF THE ANNUAL GENERAL MEETING HELD ON 28 MAY 2024
05-06
2024
Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 April 2024
First
1
2
3
4
5
Last